Renowned for its "big market brand in M&A", LCS & Partners is praised by peers as having "a strong corporate team active in the market".This year saw the firm working on several IPOs and bond issuances, such as representing for Pou Sheng International Holdings on its Hong Kong IPO, raising over $309 million and Huga Optotech on its NT$2 billion ($61 million) local primary public offering....
[more]
Renowned for its "big market brand in M&A", LCS & Partners is praised by peers as having "a strong corporate team active in the market".
This year saw the firm working on several IPOs and bond issuances, such as representing for Pou Sheng International Holdings on its Hong Kong IPO, raising over $309 million and Huga Optotech on its NT$2 billion ($61 million) local primary public offering. The firm also acted for the lead manager JS Cresvale Securities in the $45 million credit enhanced equity convertible bond offering by WonTen Technology.
Banking deals included Chinatrust Commercial Bank seeking the firm's advice on a NT$1.5 billion ($46.7 million) syndicated loan to Gala TV Corporation and other co-borrowers. The firm also worked on an acquisition financing deal, where it acted for Mega International Commercial Bank on the extension of NT$12.3 billion ($374.8 million) loans to the Carlyle Group for its acquisition of Ta Chong Bank.
Also in the banking sector, the firm turned in several M&A transactions such as the sale of liabilities, assets, and businesses of Asia Trust's seven branches to Standard Chartered Bank. The firm advised the seller in the NT$3.3 billion ($101 million) transaction.
Other notable examples include its advice to Qimonda on the $400 million sale of 36.5% stake in Inotera Memories to Micron Technology and representation for GlaxoSmithKline in its €500 million ($710.4 million) acquisition of the UCB's emerging markets business in Taiwan.
[hide]